121 related articles for article (PubMed ID: 30120022)
41. Platelet P-selectin and platelet mass, volume and component in sickle cell disease: relationship to genotype.
Mohan JS; Lip GY; Bareford D; Blann AD
Thromb Res; 2006; 117(6):623-9. PubMed ID: 16051315
[TBL] [Abstract][Full Text] [Related]
42. Impact of genetic polymorphisms in key enzymes of homocysteine metabolism on the pathophysiology of sickle cell anemia.
da Silva DGH; Belini Junior E; de Souza Torres L; Okumura JV; Marcel Barberino W; Garcia de Oliveira R; Urbinatti Teixeira V; Lopes de Castro Lobo C; Alves de Almeida E; Bonini-Domingos CR
Free Radic Biol Med; 2017 May; 106():53-61. PubMed ID: 28188925
[TBL] [Abstract][Full Text] [Related]
43. Interim assessment of liver damage in patients with sickle cell disease using new non-invasive techniques.
Drasar E; Fitzpatrick E; Gardner K; Awogbade M; Dhawan A; Bomford A; Suddle A; Thein SL
Br J Haematol; 2017 Feb; 176(4):643-650. PubMed ID: 27984631
[TBL] [Abstract][Full Text] [Related]
44. Minireview: Genetic basis of heterogeneity and severity in sickle cell disease.
Habara A; Steinberg MH
Exp Biol Med (Maywood); 2016 Apr; 241(7):689-96. PubMed ID: 26936084
[TBL] [Abstract][Full Text] [Related]
45. Incidence and natural history of proliferative sickle cell retinopathy: observations from a cohort study.
Downes SM; Hambleton IR; Chuang EL; Lois N; Serjeant GR; Bird AC
Ophthalmology; 2005 Nov; 112(11):1869-75. PubMed ID: 16171867
[TBL] [Abstract][Full Text] [Related]
46. GSTT1 (rs4025935) null genotype is associated with increased risk of sickle cell disease in the populations of Tabuk-Northwestern region of Saudi Arabia.
Abu-Duhier F; Mir R
Hematology; 2017 Apr; 22(3):172-177. PubMed ID: 27885941
[TBL] [Abstract][Full Text] [Related]
47. The influence of uridine diphosphate glucuronosyl transferase 1A promoter polymorphisms, beta-globin gene haplotype, co-inherited alpha-thalassemia trait and Hb F on steady-state serum bilirubin levels in sickle cell anemia.
Adekile A; Kutlar F; McKie K; Addington A; Elam D; Holley L; Clair B; Kutlar A
Eur J Haematol; 2005 Aug; 75(2):150-5. PubMed ID: 16004608
[TBL] [Abstract][Full Text] [Related]
48. Epigenetic analysis in placentas from sickle cell disease patients reveals a hypermethylation profile.
Gil GP; Ananina G; Maschietto M; Lima SCS; da Silva Costa SM; Baptista LC; Ito MT; Costa FF; Costa ML; de Melo MB
PLoS One; 2022; 17(9):e0274762. PubMed ID: 36129958
[TBL] [Abstract][Full Text] [Related]
49. Genome wide association study of silent cerebral infarction in sickle cell disease (HbSS and HbSC).
Brewin JN; Rooks H; Gardner K; Senior H; Morje M; Patel H; Calvet D; Bartolucci P; Thein SL; Menzel S; Rees DC
Haematologica; 2021 Jun; 106(6):1770-1773. PubMed ID: 33353285
[TBL] [Abstract][Full Text] [Related]
50. Ocular manifestations of sickle cell disease at the Korle-bu Hospital, Accra, Ghana.
Osafo-Kwaako A; Kimani K; Ilako D; Akafo S; Ekem I; Rodrigues O; Enweronu-Laryea C; Nentwich MM
Eur J Ophthalmol; 2011; 21(4):484-9. PubMed ID: 21058274
[TBL] [Abstract][Full Text] [Related]
51. Comparative studies of live neonates in maternal sickle cell haemoglobinopathy in Ghana.
Addai FK; Wilson JB; Quashie FJ
Trop Geogr Med; 1992 Oct; 44(4):312-6. PubMed ID: 1295139
[TBL] [Abstract][Full Text] [Related]
52. UGT1A1 promoter polymorphisms and the development of hyperbilirubinemia and gallbladder disease in children with sickle cell anemia.
Carpenter SL; Lieff S; Howard TA; Eggleston B; Ware RE
Am J Hematol; 2008 Oct; 83(10):800-3. PubMed ID: 18756540
[TBL] [Abstract][Full Text] [Related]
53. β-globin gene cluster haplotypes in sickle cell patients from Panamá.
Rusanova I; Cossio G; Moreno B; Javier Perea F; De Borace RG; Perea M; Escames G; Acuña-Castroviejo D
Am J Hum Biol; 2011; 23(3):377-80. PubMed ID: 21387457
[TBL] [Abstract][Full Text] [Related]
54. Natural history of blood pressure in sickle cell disease pregnancy.
Early ML; Luo A; Solow M; Matusiak K; Eke AC; Shehata N; August P; Kuo KHM; Lanzkron S; Malinowski AK; Pecker LH
Br J Haematol; 2024 Feb; 204(2):658-667. PubMed ID: 37803527
[TBL] [Abstract][Full Text] [Related]
55. Observations on the epidemiology of sickle cell disease.
Serjeant GR
Trans R Soc Trop Med Hyg; 1981; 75(2):228-33. PubMed ID: 6171077
[TBL] [Abstract][Full Text] [Related]
56. Internalizing Symptoms in Adolescents With Sickle Cell Disease.
Heitzer AM; Longoria J; Porter JS; MacArthur E; Potter B; Ding J; Gossett J; Kang G; Hankins JS
J Pediatr Psychol; 2023 Jan; 48(1):91-103. PubMed ID: 35980301
[TBL] [Abstract][Full Text] [Related]
57. Testing for the random occurrence of sickle cell disease in a study of 100,000 Jamaican newborns.
Hayes RJ; Serjeant GR
J Trop Med Hyg; 1990 Apr; 93(2):127-32. PubMed ID: 2325194
[TBL] [Abstract][Full Text] [Related]
58. Soluble P-selectin and vascular endothelial growth factor in steady state sickle cell disease: relationship to genotype.
Blann AD; Mohan JS; Bareford D; Lip GY
J Thromb Thrombolysis; 2008 Apr; 25(2):185-9. PubMed ID: 18080800
[TBL] [Abstract][Full Text] [Related]
59. Angiotensinogen M235T Gene Polymorphism is a Genetic Determinant of Cerebrovascular and Cardiopulmonary Morbidity in Adolescents with Sickle Cell Disease.
ElAlfy MS; Ebeid FSE; Kamal TM; Eissa DS; Ismail EAR; Mohamed SH
J Stroke Cerebrovasc Dis; 2019 Feb; 28(2):441-449. PubMed ID: 30409744
[TBL] [Abstract][Full Text] [Related]
60. The effect of hemolysis on plasma oxidation and nitration in patients with sickle cell disease.
Kupesiz A; Celmeli G; Dogan S; Antmen B; Aslan M
Free Radic Res; 2012 Jul; 46(7):883-90. PubMed ID: 22509726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
